StemCells CEO, CFO and three directors resigned the day of merger that boosted stock sevenfold | Traderszone

- Home
- TZ Newswire
- Business Features
- ETF's
- Futures
- Options
- Real Estate
- Stocks
- TZ Featured Lists
- TZ Latest News
- TZ Resources
Editorial Archives
Editorial Archives

Published in TZ Latest News 16 August, 2016 by The TZ Newswire Staff

StemCells CEO, CFO and three directors resigned the day of merger that boosted stock sevenfold

Merger comes as an abrupt departure from a plan to wind down the company.
read more

See also
- Next Article Pfizer’s Bold Bid to Conquer Cancer
- Previous Article “How I Met Your Mother” actress buys co-op on Babe Ruth’s floor
Editorial Calender

August 2016

M T W T F S S

1 2 3 4 5 6 7

8 9 10 11 12 13 14

15 16 17 18 19 20 21

22 23 24 25 26 27 28

29 30 31

« Jul Sep »
Recent Tags

Abnormal Returns Active management Asia Brave New World Business Chart.ly Chicago Board Options Exchange CNBC Commodities and Futures Covestor Day Trading Derivatives Equities Exchange Exchange-traded fund Funds Gawker.com GDP Gold Gold as an investment Gross domestic product High-frequency trading Hong Kong Investing Japan Market maker May 6 2010 flash crash Mutual fund National Association of Home Builders New York Mercantile Exchange Option S&P 500 SEC Standard & Poor Stock Stocks and Bonds Stock trader StockTwits Timothy Sykes Tokyo Trade Twitter U.S. Dollar Index U.S. Securities and Exchange Commission United States dollar